Unconfigured Ad
Collapse
11 results in 0.0022 seconds.
Keywords
Members
Tags
-
Stanford Team Turns Scientific Papers into Interactive AI Agents
Scholarly journals have served as the written record of scientific advancement since 1665, offering static text for people to read. A team of Stanford...
-
MetaBeeAI Helps Scientists Process Research Literature Faster
Scientific publishing is growing faster than any individual researcher can realistically keep up with, and the backlog is creating a real problem. Systematic...Last edited by SEQadmin2; 05-28-2026, 12:23 PM.
-
AI System Writes Scientific Software That Outperforms Human-Designed Code
A new artificial intelligence system can automatically write high-performance scientific software, in some cases outperforming programs built by human...
-
The Synthetic Clinical Health Records Challenge - CAMDA@ISMB2024 - July 15-16, 2024, Montreal Canada
Try your best & take the CAMDA challenge: Predict clinical endpoints from the health record histories of a million diabetes patients. Find patterns...CAMDA,CAMDA 2024,Critical Assessment of Massive Data Analysis,Critical Assessment of Microarray Data Analysis,ISMB,ECCB,MGED,FGED,FDA,SEQC,ONT,BERT,neuroblastoma,MetaSUB,metagenomics,oxford nanopore,cancer,breast cancer,metabric,data integration,toxicogenomics,TGx,DILI,personalized medicine,precision medicin,drugs,TCGA,GDC,2024
-
in ArticlesThe Impact of AI in Genomic Medicine
Artificial intelligence (AI) has evolved from a futuristic vision to a mainstream technology, highlighted by the introduction of tools like OpenAI's ChatGPT and Google's Gemini. In recent years, AI has become increasingly integrated into the field of genomics. This integration has enabled new scientific discoveries while simultaneously raising important ethical questions1. Interviews with two researchers at the center of this intersection provide insightful perspectives into... -
Current Advances and Future Directions in Rare Disease Diagnosis
- Published: 12-11-2023, 02:26 PM
- 0 comments
in ArticlesCurrent Advances and Future Directions in Rare Disease Diagnosis
Rare diseases affect an estimated 3.5–5.9% of the global population1. Patients dealing with these conditions not only face a direct impact on their health but also frequently encounter challenges in identifying the genetic origins of their disorder. This often leaves them with limited treatment options. However, the field of rare disease diagnosis has seen significant advances with the introduction of next-generation sequencing (NGS). Essential techniques like whole-exome sequencing... -
PhD student call in fields of Bioinformatics, Computational Biomedicine, Data Sci, AI
Invitation for Applications
As part of the Nordic EMBL Partnership for Molecular Medicine, FIMM in collaboration with the Doctoral School...
-
Research scientist in bioinformatics in Sweden
Protein Structure and Bioinformatics Group (http://structure.bmc.lu.se/) at Lund University, Sweden is looking for a research scientist/postdoctoral fellow...
-
Help advance postmarket surveillance techniques for FDA regulated products
Hi!
The precisionFDA Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data Challenge is now live!
...
-
The precisionFDA and Georgetown-ICBI Challenge is Live!
The goal of this challenge is to advance techniques for the prognosis and treatment of brain tumors by asking participants to develop machine learning...
-
precisionFDA and Georgetown-ICBI are launching the Brain Cancer Predictive Modeling a
The goal of this challenge is to advance techniques for the prognosis and treatment of brain tumors by asking participants to develop machine learning...